Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Net Sales
214.52
Other Operating Income
0.00
Total Operating income
214.52
Raw Material Cost
31.96
Purchase of Finished goods
70.30
(Increase) / Decrease In Stocks
3.88
Employee Cost
35.46
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
31.32
Total Expenditure (Excl Depreciation)
172.92
Operating Profit (PBDIT) excl Other Income
41.60
Other Income
2.82
Operating Profit (PBDIT)
44.42
Interest
9.45
Exceptional Items
0.00
Gross Profit (PBDT)
34.97
Depreciation
10.02
Profit Before Tax
24.95
Tax
-7.76
Provisions and contingencies
0.00
Profit After Tax
32.71
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
32.71
Share in Profit of Associates
0.00
Minority Interest
-1.26
Other related items
0.00
Consolidated Net Profit
31.45
Equity Capital
30.51
Face Value
10.0
Reserves
173.76
Earnings per share (EPS)
10.31
Diluted Earnings per share
12.21
Operating Profit Margin (Excl OI)
19.39%
Gross Profit Margin
16.3%
PAT Margin
15.25%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 174.72%
Standalone Net Profit
YoY Growth in year ended Mar 2024 is -32.50%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 96.07%
Interest
YoY Growth in year ended Mar 2024 is 26.64%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Senores Pharma. With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
214.52
10,334.77
-10,120.25
-97.92%
Other Operating Income
0.00
0.00
0.00
Total Operating income
214.52
10,334.77
-10,120.25
-97.92%
Raw Material Cost
31.96
1,853.52
-1,821.56
-98.28%
Purchase of Finished goods
70.30
1,409.85
-1,339.55
-95.01%
(Increase) / Decrease In Stocks
3.88
-53.67
57.55
107.23%
Employee Cost
35.46
2,274.73
-2,239.27
-98.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
31.32
2,315.28
-2,283.96
-98.65%
Total Expenditure (Excl Depreciation)
172.92
7,799.71
-7,626.79
-97.78%
Operating Profit (PBDIT) excl Other Income
41.60
2,535.06
-2,493.46
-98.36%
Other Income
2.82
280.86
-278.04
-99.00%
Operating Profit (PBDIT)
44.42
2,815.92
-2,771.50
-98.42%
Interest
9.45
33.53
-24.08
-71.82%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
34.97
2,782.39
-2,747.42
-98.74%
Depreciation
10.02
398.25
-388.23
-97.48%
Profit Before Tax
24.95
2,384.14
-2,359.19
-98.95%
Tax
-7.76
457.58
-465.34
-101.70%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
32.71
1,926.56
-1,893.85
-98.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
32.71
1,926.56
-1,893.85
-98.30%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
-1.26
-28.87
27.61
95.64%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.45
1,912.90
-1,881.45
-98.36%
Equity Capital
30.51
40.06
-9.55
-23.84%
Face Value
10.00
1.00
0.00
Reserves
173.76
9,323.03
-9,149.27
-98.14%
Earnings per share (EPS)
10.31
47.75
-37.44
-78.41%
Diluted Earnings per share
12.21
47.68
-35.47
-74.39%
Operating Profit Margin (Excl OI)
19.39%
24.53%
0.00
-5.14%
Gross Profit Margin
16.30%
26.92%
0.00
-10.62%
PAT Margin
15.25%
18.79%
0.00
-3.54%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 34.01 Cr
in Mar 2024Figures in Rs Cr
Annual - Standalone Net Profit
Standalone Net Profit 0.81 Cr
in Mar 2024Figures in Rs Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.07 Cr
in Mar 2024Figures in Rs Cr
Annual - Interest
Interest 2.71 Cr
in Mar 2024Figures in Rs Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.21%
in Mar 2024Figures in Rs %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
